ProShare Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,202
Closed -$172K 2338
2021
Q4
$172K Buy
+11,202
New +$147K ﹤0.01% 2085
2021
Q3
Sell
-13,086
Closed -$134K 2359
2021
Q2
$134K Sell
13,086
-179
-1% -$1.89K ﹤0.01% 2240
2021
Q1
$159K Buy
13,265
+2,265
+21% +$25.7K ﹤0.01% 2093
2020
Q4
$100K Buy
+11,000
New +$85.1K ﹤0.01% 1989
2014
Q2
Sell
-20,405
Closed -$162K 2660
2014
Q1
$162K Buy
+20,405
New +$152K ﹤0.01% 2590
2013
Q4
Sell
-12,820
Closed -$95K 1989
2013
Q3
$95K Buy
12,820
+205
+2% +$1.6K ﹤0.01% 2430
2013
Q2
$110K Buy
+12,615
New +$81.1K ﹤0.01% 2223

Other funds holding NPTN

ProShare Advisors's NPTN Position: Q1 2022 in Review

ProShare Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 11,202 shares — an estimated $172K sold.

ProShare Advisors first reported a position in NPTN in Q2 2013 and held it in 7 quarters. The position peaked at $172K in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • ProShare Advisors reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 11,202 NEOPHOTONICS CORP shares in Q1 2022, an estimated $172K.
  • ProShare Advisors first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 7 quarters.
  • ProShare Advisors's NEOPHOTONICS CORP position peaked at $172K in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.